Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Folate Biomarkers, Folate Intake, and Risk of Death From All Causes, Cardiovascular Disease, and Cancer: A Systematic Review and Dose-Response Meta-Analysis of Prospective Cohort Studies Publisher Pubmed



Fallah M1 ; Dehnavi MK1, 2 ; Lotfi K1, 2 ; Aminianfar A3 ; Azadbakht L1, 4 ; Esmaillzadeh A1, 5, 6
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Community Nutrition, School of Nutritional Sciences and Dietetics, Tehran University of Medical Sciences, Tehran, 14155-6117, Iran
  2. 2. Students’ Scientific Research Center, Tehran University of Medical Sciences, Tehran, 14155-6117, Iran
  3. 3. Research Center for Biochemistry and Nutrition in Metabolic Diseases, Kashan University of Medical Sciences, Kashan, Iran
  4. 4. Diabetes Research Centre, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, 14155-6117, Iran
  5. 5. Obesity and Eating Habits Research Center, Endocrinology and Metabolism Molecular–Cellular Sciences Institute, Tehran University of Medical Sciences, Tehran, 14155-6117, Iran
  6. 6. Department of Community Nutrition, School of Nutrition and Food Science, Isfahan University of Medical Sciences, Isfahan, 81745, Iran

Source: Nutrition Reviews Published:2025


Abstract

Context: Existing evidence on the relation between folate intake and biomarkers with mortality risk is controversial. Objective: Previous cohort studies were examined regarding folate intake and biomarkers in relation to risk of all-cause, cardiovascular disease– (CVD), and cancer-related mortality through a systematic review and meta-analysis. Data Sources: A systematic search was performed of the PubMed, Scopus, and ISI Web of Science databases up to July 2023. Data Extraction: Prospective cohort studies examining the association of folate biomarkers (in serum, plasma, red blood cells) and intake with risk of all-cause, CVD-, and cancer-related mortality were considered. A random-effects model was applied to combine study-specific risk estimates. Dose-response relations were assessed by 1-stage weighted mixed-effects meta-analysis. Data Analysis: A total of 25 cohorts with 423 304 participants, 36558 all-cause, 12 662 CVD-, and 2426 cancer-related deaths were included. No significant association was observed between the highest levels of folate biomarkers and all-cause mortality risk (hazard ratio [HR], 0.91; 95% CI, 0.77-1.06; n = 17; I2 = 89.4%; P< .001), CVD-related mortality risk (HR, 0.97; 95% CI, 0.87-1.06; n = 11; I2 = 0.0%; P = .57), and cancer-related mortality risk (HR, 0.85; 95% CI, 0.69-1.05; n = 6; I2 = 57.8%; P = .04) compared with the lowest. Furthermore, each 10nmol/L increase was marginally related to a 12% reduced all-cause mortality risk but not to CVD- and cancer-related mortality risk. A significant inverse association was found between highest intake of dietary folate and the lowest, and risk of all-cause (HR, 0.87; 95% CI, 0.78-0.96; n = 3; I2 = 63.6%; P = .06) and CVD (HR, 0.77; 95% CI, 0.57-0.93; n = 4; I2 = 80.2%; P = .002) mortality. Conclusions: This meta-analysis revealed a significant inverse relation between dietary folate intake and risk of all-cause and CVD mortality. Such an association was not found in the case of folate biomarkers. Further prospective studies are warranted to confirm these findings. © The Author(s) 2024. Published by Oxford University Press on behalf of the International Life Sciences Institute.
3. Folic Acid Intake and Risk of Breast Cancer, Journal of Isfahan Medical School (2018)
Experts (# of related papers)
Other Related Docs
23. Effect of Vitamins C and E on Cancer Survival; a Systematic Review, DARU, Journal of Pharmaceutical Sciences (2022)